: MindMed announces positive results in trial of LSD as a treatment for generalized anxiety disorder

<p>Mind Medicine Inc. MNMD said Thursday a Phase 2 trial testing LSD as a treatment for generalized anxiety disorder met its main goal, showing a statistically significant improvement in scores by week four compared to placebo. The trial of MM-120 was administered as a single dose in a monitored clinical setting with no additional therapeutic […]</p>
<p>The post <a href="https://forextv.com/market-news/mindmed-announces-positive-results-in-trial-of-lsd-as-a-treatment-for-generalized-anxiety-disorder/">: MindMed announces positive results in trial of LSD as a treatment for generalized anxiety disorder</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>